MERCK SHARP & DOHME CORP. v. AUROBINDO PHARMA USA INC. et al > Summary
Court Case Number 3:20-cv-10444
Filing Date Aug 13, 2020
Termination Date Dec 22, 2020
Court New Jersey District Court
Status Judgment - Judgment on Consent
Plaintiff
Plaintiff Attorneys
7Merck Sharp & Dohme
Attorney Name: John E. Flaherty
McCarter & English
Merck Sharp & Dohme
Attorney Name: Cynthia S. Betz
McCarter & English
Merck Sharp & Dohme
Attorney Name: Tracey B. Davies
Gibson Dunn & Crutcher
Merck Sharp & Dohme
Attorney Name: Mark N. Reiter
Gibson Dunn & Crutcher
Merck Sharp & Dohme
Attorney Name: Philip J. Spear
Gibson Dunn & Crutcher
Merck Sharp & Dohme
Attorney Name: David L. Glandorf
Gibson Dunn & Crutcher
Merck Sharp & Dohme
Attorney Name: Ashbey N. Morgan
Gibson Dunn & Crutcher
Defendant Attorneys
6Aurobindo Pharma USA
Attorney Name: Marc D. Youngelson
Cosner Law Group
AuroMedics Pharma
Attorney Name: Marc D. Youngelson
Cosner Law Group
Aurobindo Pharma
Attorney Name: Marc D. Youngelson
Cosner Law Group
AuroMedics Pharma
Attorney Name: James E. Nealon
Withersworldwide
AuroMedics Pharma
Attorney Name: Steven Jerome Moore
Withersworldwide
Aurobindo Pharma USA
Attorney Name: Steven Jerome Moore
Withersworldwide
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
09358297 | Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin | Jun 7, 2016 |
09023790 | Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin | May 5, 2015 |